June 10, 2020 / 2:47 AM / a month ago

BRIEF-Illumina Receives First FDA Emergency Use Authorization For A Sequencing-Based Covid-19 Diagnostic Test

June 9 (Reuters) - Illumina Inc:

* ILLUMINA RECEIVES FIRST FDA EMERGENCY USE AUTHORIZATION FOR A SEQUENCING-BASED COVID-19 DIAGNOSTIC TEST

* U.S. FDA ISSUED AN EMERGENCY USE AUTHORIZATION FOR ILLUMINA COVIDSEQ TEST

* COVIDSEQ IS CURRENTLY AVAILABLE TO A LIMITED NUMBER OF EARLY ACCESS SITES, IS EXPECTED TO BE MORE BROADLY AVAILABLE THIS SUMMER

* OVIDSEQ HAS NOT BEEN FDA CLEARED OR APPROVED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below